Radiopharm Theranostics Limited (RADX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Radiopharm Theranostics L...

NASDAQ: RADX · Real-Time Price · USD
6.20
0.14 (2.31%)
At close: Oct 03, 2025, 3:55 PM
6.29
1.45%
After-hours: Oct 03, 2025, 05:41 PM EDT

Radiopharm Theranostics Cash Flow Statement

Financials in AUD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2025 Jun 30, 2024 Jun 30, 2023 Jun 30, 2022
Net Income
n/a -47.95M -34.61M -30.34M
Depreciation & Amortization
n/a n/a n/a n/a
Stock-Based Compensation
n/a n/a n/a n/a
Other Working Capital
n/a n/a n/a n/a
Other Non-Cash Items
-36.65M 24.97M 11.41M 20.42M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
n/a n/a n/a n/a
Operating Cash Flow
-36.65M -22.98M -23.2M -9.92M
Capital Expenditures
n/a n/a -1.53M -28.34M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
1.77M -320K -1.49M -28.37M
Investing Cash Flow
1.77M -320K -1.53M -28.37M
Debt Repayment
-1.9M 2.2M n/a -59K
Common Stock Repurchased
n/a -1.53M -854.76K -4.83M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-6.65M -117K n/a n/a
Financial Cash Flow
45.43M 30.2M 9.22M 65.11M
Net Cash Flow
10.54M 6.88M -15.28M 26.95M
Free Cash Flow
-36.65M -22.98M -24.73M -38.25M